What does MEDIVET do?

MEDIVET is a veterinary practice in Harelbeke. Private Limited, started on 18 June 1997, 1 establishment.

What is the address of MEDIVET?

The registered office of MEDIVET is located at Klein-Harelbekestraat 24, 8531 Harelbeke.

Is MEDIVET still active?

Yes. According to the CBE (30 October 2026) MEDIVET is active, legal situation “Normale toestand”, started on 18 June 1997.

Is MEDIVET registered on Peppol?

Yes, MEDIVET is registered on the Peppol network with ID 0208:0460889461.

What is the enterprise number of MEDIVET?

The enterprise number of MEDIVET is BE0460889461.

When was MEDIVET founded?

MEDIVET was founded on 18 June 1997.

Who are the directors of MEDIVET?

According to the 2025 annual accounts, the directors of MEDIVET are: Alain Vanneste.

Is MEDIVET a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 June 1997; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDIVET make in 2025?

MEDIVET posted a profit after taxes of € 383,986 in financial year 2025.

What is the revenue of MEDIVET?

As a small company, MEDIVET is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 718,004.

MEDIVET (Private Limited) - Harelbeke - BE0460889461

Dossier MEDIVET, printed on 30 October 2026 from databakkes.be/en/0460889461/medivet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDIVET from Harelbeke, company number BE0460889461, closed financial year 2025 with a result of € 383,986 after tax. For that financial year MEDIVET recorded a gross margin of € 718,004 and equity of € 1.6 million. Compared with financial year 2024, the result moved from € 183,276 to € 383,986. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 6, 2026.

What it is worth Growing

€ 1.6 million

▲ 28% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 383,986

▲ 110% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 172,851

▼ 74% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 36,000 paid out

9 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 20,539

▼ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 24 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.1 million

▼ 24% vs 2024

€ 46,440 is repaid this year. At this pace the long-term loan is gone in ≈ 24 years.

Owed to suppliers

€ 46,598

▼ 67% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 15,450

▼ 89% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 93,105 Gross margin 2022: € 93,105 First fiscal year in the series	€ 370,940 Gross margin 2023: € 370,940 ▲ 298% vs 2022 (€ 93,105) Favourable step	€ 632,468 Gross margin 2024: € 632,468 ▲ 71% vs 2023 (€ 370,940) Favourable step	€ 718,004 Gross margin 2025: € 718,004 ▲ 14% vs 2024 (€ 632,468) Favourable step	▲ 14%
Profit after taxes	€ 71,949 Profit after taxes 2022: € 71,949 First fiscal year in the series	€ 176,712 Profit after taxes 2023: € 176,712 ▲ 146% vs 2022 (€ 71,949) Favourable step	€ 183,276 Profit after taxes 2024: € 183,276 ▲ 4% vs 2023 (€ 176,712) Favourable step	€ 383,986 Profit after taxes 2025: € 383,986 ▲ 110% vs 2024 (€ 183,276) Favourable step	▲ 110%
Equity	€ 870,918 Equity 2022: € 870,918 First fiscal year in the series	€ 1,047,630 Equity 2023: € 1,047,630 ▲ 20% vs 2022 (€ 870,918) Favourable step	€ 1,230,906 Equity 2024: € 1,230,906 ▲ 17% vs 2023 (€ 1,047,630) Favourable step	€ 1,578,893 Equity 2025: € 1,578,893 ▲ 28% vs 2024 (€ 1,230,906) Favourable step	▲ 28%
Total debts	€ 950,668 Total debts 2022: € 950,668 First fiscal year in the series	€ 1,458,809 Total debts 2023: € 1,458,809 ▲ 53% vs 2022 (€ 950,668) Unfavourable step	€ 1,960,317 Total debts 2024: € 1,960,317 ▲ 34% vs 2023 (€ 1,458,809) Unfavourable step	€ 1,398,205 Total debts 2025: € 1,398,205 ▼ 29% vs 2024 (€ 1,960,317) Favourable step	▼ 29%
Cash	€ 778,381 Cash 2022: € 778,381 First fiscal year in the series	€ 255,410 Cash 2023: € 255,410 ▼ 67% vs 2022 (€ 778,381) Unfavourable step	€ 655,846 Cash 2024: € 655,846 ▲ 157% vs 2023 (€ 255,410) Favourable step	€ 172,851 Cash 2025: € 172,851 ▼ 74% vs 2024 (€ 655,846) Unfavourable step	▼ 74%
Land & buildings	€ 230,812 Land & buildings 2022: € 230,812 First fiscal year in the series	€ 946,732 Land & buildings 2023: € 946,732 ▲ € 715,919 vs 2022 (€ 230,812) Unchanged	€ 1,727,265 Land & buildings 2024: € 1,727,265 ▲ 82% vs 2023 (€ 946,732) Unchanged	€ 2,080,263 Land & buildings 2025: € 2,080,263 ▲ 20% vs 2024 (€ 1,727,265) Unchanged	▲ 20%
Retained profit	€ 858,510 Retained profit 2022: € 858,510 First fiscal year in the series	€ 1,035,222 Retained profit 2023: € 1,035,222 ▲ 21% vs 2022 (€ 858,510) Favourable step	€ 1,218,498 Retained profit 2024: € 1,218,498 ▲ 18% vs 2023 (€ 1,035,222) Favourable step	€ 1,566,485 Retained profit 2025: € 1,566,485 ▲ 29% vs 2024 (€ 1,218,498) Favourable step	▲ 29%
Dividend	€ 401,207 Dividend 2022: € 401,207 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 401,207) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 36,000 Dividend 2025: € 36,000 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 762,608 Bank debt 2023: € 762,608 Unchanged (€ 0) Unfavourable step	€ 1,471,202 Bank debt 2024: € 1,471,202 ▲ 93% vs 2023 (€ 762,608) Unfavourable step	€ 1,116,639 Bank debt 2025: € 1,116,639 ▼ 24% vs 2024 (€ 1,471,202) Favourable step	▼ 24%
Balance sheet total	€ 1,858,517 Balance sheet total 2022: € 1,858,517 First fiscal year in the series	€ 2,542,612 Balance sheet total 2023: € 2,542,612 ▲ 37% vs 2022 (€ 1,858,517) Unchanged	€ 3,214,639 Balance sheet total 2024: € 3,214,639 ▲ 26% vs 2023 (€ 2,542,612) Unchanged	€ 2,999,757 Balance sheet total 2025: € 2,999,757 ▼ 7% vs 2024 (€ 3,214,639) Unchanged	▼ 7%

Key figures of MEDIVET, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDIVET?

What happened at MEDIVET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 6, 2026 New annual accounts for financial year 2025: profit of € 383,986 (▲ 110% vs 2024). filed late Source: NBB ↗
1997 Alain Vanneste became a director. NBB
Jun 18, 1997 Start of the company according to the CBE. KBO
Jun 13, 1997 New establishment in Wielsbeke. KBO

In short

From € 71,949 profit in 2022 to € 383,986 profit in 2025.

Paid € 372,581 in corporate taxes since 2022.

Best year ever: 2025, with € 383,986 profit.

Paid out € 437,207 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Alain Vanneste

MEDIVET

DAP MEDIPRO BV 25%

Behind MEDIVET is Alain Vanneste. It owns 25% of DAP MEDIPRO BV itself.

Directors

According to the 2025 annual accounts

Alain Vanneste

Director

since 1997

Establishments

Establishment units

Physical locations of this company

Registered office

Klein-Harelbekestraat 24

8531 Harelbeke

2.193.658.661

Heirweg 144 box A

8710 Wielsbeke

Active since 13 June 1997

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0460.889.461
VAT number: BE 0460.889.461
Registered office: Klein-Harelbekestraat 24, 8531 Harelbeke
Names & denominations: MEDIVET
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 June 1997
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Veterinaire diensten

View on CBE Public ↗ Annual accounts (NBB) ↗